{"acute myeloid leukaemia": 3.5, "agranulocytosis": 2.53, "alopecia": 3.14, "anaemia": 2.08, "anaphylactic shock": 2.93, "brain neoplasm": 4.23, "breast cancer": 4.77, "breast cancer metastatic": 15.48, "breast cancer recurrent": 39.24, "cardiac disorder": 2.77, "cardiac dysfunction": 66.51, "cardiac failure": 13.06, "cardiac failure acute": 6.52, "cardiac failure congestive": 2.21, "cardiomyopathy": 14.39, "cardiotoxicity": 50.06, "central nervous system lesion": 3.84, "dehydration": 2.56, "dermatitis acneiform": 4.0, "diarrhoea": 3.73, "dilated cardiomyopathy": 4.95, "disease progression": 7.27, "drug-induced liver injury": 2.55, "dry skin": 2.7, "ejection fraction abnormal": 26.97, "ejection fraction decreased": 90.68, "epistaxis": 2.0, "febrile neutropenia": 6.06, "granulocyte count decreased": 12.53, "granulocytopenia": 7.31, "hair colour changes": 5.59, "hair texture abnormal": 10.27, "hepatic function abnormal": 3.31, "her2 positive breast cancer": 116.75, "hypersensitivity": 2.63, "hypertransaminasaemia": 4.27, "hypokalaemia": 2.15, "ill-defined disorder": 5.94, "infusion related reaction": 21.04, "intentional product use issue": 3.41, "interstitial lung disease": 6.32, "invasive ductal breast carcinoma": 9.5, "lacrimation increased": 3.1, "left ventricular dysfunction": 17.21, "leukopenia": 2.18, "liver function test increased": 2.29, "liver injury": 2.5, "lung disorder": 2.4, "lung infiltration": 3.87, "lymphoedema": 6.2, "madarosis": 12.85, "metastases to bone": 8.04, "metastases to central nervous system": 27.2, "metastases to liver": 7.44, "metastases to lung": 8.62, "metastases to lymph nodes": 7.51, "metastasis": 6.6, "metastatic neoplasm": 15.95, "mitral valve incompetence": 6.96, "mucosal inflammation": 8.4, "myelosuppression": 20.28, "nail disorder": 16.45, "neoplasm": 3.87, "neuropathy peripheral": 7.72, "neutropenia": 3.12, "neutrophil count decreased": 9.1, "no adverse event": 3.24, "onychoclasis": 9.16, "onychomadesis": 18.97, "oral pain": 2.09, "oxygen saturation decreased": 2.35, "palmar-plantar erythrodysaesthesia syndrome": 4.67, "paronychia": 7.45, "pericardial effusion": 3.26, "peripheral sensory neuropathy": 5.09, "platelet count decreased": 5.48, "pleural effusion": 3.36, "pneumonitis": 3.81, "polyneuropathy": 3.83, "pregnancy": 5.89, "pulmonary fibrosis": 3.9, "pulmonary mass": 2.55, "pulmonary toxicity": 4.21, "recurrent cancer": 9.41, "red blood cell count decreased": 3.22, "shock": 2.52, "skin fissures": 5.14, "stomatitis": 3.77, "temperature intolerance": 4.8, "thrombocytopenia": 2.05, "tumour lysis syndrome": 3.65, "white blood cell count decreased": 7.49}